معرفی
Michael Welsh, MD, is a Professor at the University of Iowa Carver College of Medicine, holding appointments in Internal Medicine, Molecular Physiology and Biophysics, Neurology, and Neurosurgery. As director of the Pappajohn Biomedical Institute and a former Howard Hughes Medical Institute investigator (1989–2024), his work bridges fundamental science and clinical innovation.
- Born and trained in Iowa, Welsh has dedicated over 40 years to studying cystic fibrosis (CF) and lung biology
- His research revealed the CFTR protein’s role as a chloride ion channel and developed mutation-specific therapies
Welsh’s discoveries enabled breakthroughs like Trikafta, a therapy addressing root causes of CF rather than symptoms. His work has transformed CF from a fatal condition to a manageable disease, impacting 90% of patients globally. Beyond CF, his studies on protein misfolding offer frameworks for treating Parkinson’s, Alzheimer’s, and other disorders.
Scientific Awards
- 2025 Canada Gairdner International Award (for CF research)
- 2022 Shaw Prize in Life Sciences & Medicine
- 2023 Wiley Prize
- 2023 Switzer Prize
- 2020 George M. Kober Medal
- 2018 Warren Alpert Foundation Prize
- 2017 Steven C. Beering Award
Welsh’s leadership in the American Society for Clinical Investigation and Association of American Physicians, alongside memberships in the National Academy of Sciences, National Academy of Medicine, and American Academy of Arts and Sciences, underscores his influence in biomedical science.
